AXOGEN INC
AXGNNASDAQ🏆 #1808 by market capEarnings Oct 28 · PreUS Equity
$49.25▲ $11.79 (+31.47%)
🌙 After hours$49.44▲ 0.39%Regular close · extended-hours price shownTrack AXGN
Get earnings, price moves & breaking news on Telegram
24h▲ 31.5%
7d▲ 35.0%
14d▲ 40.2%
30d▲ 13.5%
ytd▲ 50.7%
1y▲ 172.4%
🏦Market Cap
$2.88B
Small Cap
📈Revenue Growth (YoY)
23.6%
Healthy
📊Gross Margin
74.6%
High
💵FCF Margin
3.1%
Moderate
⚖️P/S Ratio
8.9x
Elevated
Otter Score
72
Strong
AXOGEN INC
AXGNAnalyst Ratings
Price
$49.25
Total
21
Raised
1
Lowered
3
Avg PT
$54.86
H / L
$65 / $50
| Institution | Action | Rating | Date | Upside | |
|---|---|---|---|---|---|
Barclays | Reiterated | Overweight | 2026-10-23 | $50.00 | +1.50% |
Truist Securities | Reiterated | Buy | 2026-10-01 | — | — |
Raymond James | Reiterated | Outperform | 2026-09-25 | $53.00 | +7.60% |
Canaccord Genuity | Reiterated | Buy | 2026-07-30 | $50.00 | +1.50% |
HC Wainwright & Co. | Reiterated | Buy | 2026-07-30 | — | — |
Citizens | Reiterated | Market Outperform | 2026-07-30 | — | — |
Wells Fargo | Reiterated | Overweight | 2026-04-29 | $40.00 | −18.80% |
Lake Street | Reiterated | Buy | 2026-04-23 | $40.00 | −18.80% |
Jefferies | Reiterated | Buy | 2025-12-04 | $60.00 | +21.80% |
Citizens Capital Markets | Reiterated | Market Outperform | 2025-03-05 | — | — |
Cantor Fitzgerald | Reiterated | Overweight | 2025-03-05 | — | — |
JMP Securities | Reiterated | Market Outperform | 2024-08-09 | $34.00 | −31.00% |
SVB Leerink | Reiterated | Outperform | 2022-05-05 | — | — |
Guggenheim | Reiterated | Buy | 2020-10-23 | — | — |
BTIG | Downgraded | Buy → Neutral | 2020-04-02 | — | — |
William Blair | Downgraded | Outperform → Market Perform | 2019-08-07 | — | — |
BTIG Research | Upgraded | Neutral → Buy | 2019-03-25 | — | — |
Leerink Swann | Reiterated | Outperform | 2017-11-21 | — | — |
Roth Capital | Reiterated | Buy | 2017-03-06 | — | — |
Ladenburg Thalmann | Downgraded | Buy → Neutral | 2015-04-01 | — | — |
Wedbush | Reiterated | Outperform | 2015-03-12 | — | — |
Institution
Barclays
Reiterated · Overweight · 2026-10-23
$50.00
+1.50%
Truist Securities
Reiterated · Buy · 2026-10-01
—
—
Raymond James
Reiterated · Outperform · 2026-09-25
$53.00
+7.60%
Canaccord Genuity
Reiterated · Buy · 2026-07-30
$50.00
+1.50%
HC Wainwright & Co.
Reiterated · Buy · 2026-07-30
—
—
Citizens
Reiterated · Market Outperform · 2026-07-30
—
—
Wells Fargo
Reiterated · Overweight · 2026-04-29
$40.00
−18.80%
Lake Street
Reiterated · Buy · 2026-04-23
$40.00
−18.80%
Jefferies
Reiterated · Buy · 2025-12-04
$60.00
+21.80%
Citizens Capital Markets
Reiterated · Market Outperform · 2025-03-05
—
—
Cantor Fitzgerald
Reiterated · Overweight · 2025-03-05
—
—
JMP Securities
Reiterated · Market Outperform · 2024-08-09
$34.00
−31.00%
SVB Leerink
Reiterated · Outperform · 2022-05-05
—
—
Guggenheim
Reiterated · Buy · 2020-10-23
—
—
BTIG
Downgraded · Buy → Neutral · 2020-04-02
—
—
William Blair
Downgraded · Outperform → Market Perform · 2019-08-07
—
—
BTIG Research
Upgraded · Neutral → Buy · 2019-03-25
—
—
Leerink Swann
Reiterated · Outperform · 2017-11-21
—
—
Roth Capital
Reiterated · Buy · 2017-03-06
—
—
Ladenburg Thalmann
Downgraded · Buy → Neutral · 2015-04-01
—
—
Wedbush
Reiterated · Outperform · 2015-03-12
—
—
One row per institution · price target from the firm's latest published target
StockOtter · stockotter.space